CENTRAL GARDEN & PET CO
For the period ended Mar 28, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 28, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 27, 2025.
The following table sets forth the repurchases of any equity securities during the fiscal quarter ended March 28, 2026 and the dollar amount of authorized share repurchases remaining under our stock repurchase program.
| Period · Total Number of Shares (or Units) Purchased · AveragePrice Paid per Share (or Units) · Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (1)(2) · Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs (1)(2) | ||||||
|---|---|---|---|---|---|---|
| December 28, 2025 - January 31, 2026 | 45,236 | (2) (3) | $29.45 | 23,346 | $27,976,000 | |
| February 1, 2026 - February 28, 2026 | 103,350 | (3) | 33.87 | — | 127,976,000 | |
| March 1, 2026 - March 28, 2026 | 86,919 | (2) | 31.62 | 86,919 | 127,976,000 | |
| Total | 235,505 | $32.19 | 110,265 | (4) | $127,976,000 | |
(1)In December 2024, our Board of Directors authorized a $100 million increase in our share repurchase program (the "2024 Repurchase Authorization”). The 2024 Repurchase Authorization has no fixed expiration date and expires when the amount authorized has been used or the Board withdraws its authorization. In February 2026, our Board of Directors authorized a $100 million increase in our share repurchase program (the "2026 Repurchase Authorization”). The 2026 Repurchase Authorization has no fixed expiration date and expires when the amount authorized has been used or the Board withdraws its authorization. The repurchase of shares may be limited by certain financial covenants in our credit facility that restrict our ability to repurchase our stock. As of March 28, 2026, we had $128.0 million of authorization remaining under our 2026 Repurchase Authorization and 2024 Repurchase Authorization, collectively.
(2)In February 2019, our Board of Directors authorized us to make supplemental stock purchases to minimize dilution resulting from issuances under our equity compensation plans (the “Equity Dilution Authorization”). In addition to our regular share repurchase program, we are permitted to purchase annually a number of shares equal to the number of shares of restricted stock and stock options granted in the prior fiscal year, to the extent not already repurchased, and the current fiscal year. The Equity Dilution Authorization has no fixed expiration date and expires when the Board withdraws its authorization. There were 414,205 shares remaining under our Equity Dilution Authorization as of March 28, 2026.
(3)Shares purchased during the period indicated include withholding of a portion of shares to cover taxes in connection with the vesting of restricted stock and do not reduce the dollar value of shares that may be purchased under our stock repurchase plan.
(4)During the period, we repurchased 110,265 CENTA shares under the Equity Dilution Authorization.
Not applicable
Not applicable
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.